Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Infant Bacterial Therapeutics AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 More Arrow 26 More Arrow 40
Earnings before taxes -11,091 More Arrow -5,881 More Arrow -4,399
EBITDA -12,132 More Arrow -5,914 More Arrow -4,359
Total assets 31,663 Less Arrow 31,417 More Arrow 39,942
Current assets 30,783 Less Arrow 30,466 More Arrow 38,828
Current liabilities 4,162 Less Arrow 1,610 Less Arrow 1,293
Equity capital 27,501 More Arrow 29,807 More Arrow 38,648
- share capital 331 Less Arrow 275 More Arrow 299
Employees (average) 8 Less Arrow 7 More Arrow 8

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 86.9% More Arrow 94.9% More Arrow 96.8%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -35.0% More Arrow -18.6% More Arrow -10.9%
Current ratio 739.6% More Arrow 1892.3% More Arrow 3002.9%
Return on equity (ROE) -40.3% More Arrow -19.7% More Arrow -11.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 1 Less Arrow -1 Less Arrow -2
Chg. No. of employees % 14% Less Arrow -13% Less Arrow -20%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.